NeoImmuneTech, Inc, a T cell-focused therapeutics company, presented data that suggests that NT-I7 plus pembrolizumab combination treatment enhances infiltration of PD-1+ T cells in...
Avails Medical, a pioneer in rapid, automated and fully electrical antibiotic susceptibility testing (eAST™) announced the commencement of U.S. pivotal clinical trials for its...
RegeneRx Biopharmaceuticals, Inc., a clinical-stage drug development company focused on tissue protection, repair, and regeneration, is reporting today that its U.S. joint venture (JV)...
GrowLab Pharmaceuticals PLC ("GrowLab") recorded 96% Clinical Diabetes Remission following independent clinical trials of its phytocannabinoids based therapeutic Comacadine curated and synthesised from its...
